Molecular Therapy Molecular Therapy is the leading journal for research in the areas of gene transfer, vector development and design, stem cell manipulation, development of gene-, peptide-, protein-, oligonucleotide-, and cell-based therapeutics to correct genetic and acquired diseases, vaccine development, pre-clinical target validation, safety/efficacy studies, and clinical trials. Molecular Therapy is dedicated to promoting the sciences in genetics, medicine, and biotechnology. Publishing important peer-reviewed research and cutting-edge reviews and commentaries, the journal continues to attract the best material in the field. Molecular Therapy's 2022 impact factor is 12.4.

Visit the Cell Press website for more information about Molecular Therapy - http://www.cell.com/molecular-therapy-family/home

Editor-in-Chief
Seppo Ylä-Herttuala, MD, PhD
Dept. of Biotechnology and Molecular Medicine
University of Eastern Finland, A.I.Virtanen Institute
P.O. Box 1627
Kuopio 70211, Finland
Tel: +358 40 355 2075
Email: seppo.ylaherttuala@uef.fi
Executive Editor
Robert M Frederickson, PhD
Molecular Therapy Editorial Office
710 Summit Avenue East
Seattle, WA 98102
Tel: +1 323-989-7070
Email: editor@molther.org
详见：https://www.cell.com/molecular-therapy-family/editors